특집 : 조혈모세포이식을 위한 최적의 제대혈 선택 지침

논문상세정보
' 특집 : 조혈모세포이식을 위한 최적의 제대혈 선택 지침' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • algorithm
  • cordbloodtransplantation
  • guideline
  • selection
  • 선택
  • 알고리즘
  • 제대혈이식
  • 지침
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,199 0

0.0%

' 특집 : 조혈모세포이식을 위한 최적의 제대혈 선택 지침' 의 참고문헌

  • Umbilical cordblood transplantation: the first 25 years and beyond
    Ballen KK Blood 122 : 491 ~ 498 - [2013]
  • The impact ofanti-HLA antibodies on unrelated cord blood transplantations
    Takanashi M Blood 116 : 2839 ~ 2846 - [2010]
  • Reexposure of cord blood to noninheritedmaternal HLA antigens improves transplant outcome inhematological malignancies
    Van Rood JJ Proc Natl Acad Sci U S A 106 : 19952 ~ 19957 [2009]
  • Recommendations for astandard UK approach to incorporating umbilical cordblood into clinical transplantation practice: conditioningprotocols and donor selection algorithms
    Shaw BE Bone MarrowTransplant 44 : 7 ~ 12 - [2009]
  • Microchimerism: tolerance vs.sensitization
    Dutta P Curr Opin Organ Transplant 16 : 359 ~ 365 - [2011]
  • Improving outcomes in umbilical cord blood transplantation: state of the art
    Cutler C Blood Rev 26 : 241 ~ 246 [2012]
  • Impact of donorspecificanti-HLA antibodies on graft failure and survivalafter reduced intensity conditioning-unrelated cord bloodtransplantation: a Eurocord, Societe Francophone d'Histocompatibiliteet d'Immunogenetique (SFHI) and SocieteFrancaise de Greffe de Moelle et de Therapie Cellulaire(SFGM-TC) analysis
    Ruggeri A Haematologica 98 : 1154 ~ 1160 - [2013]
  • Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy
    Eapen M Blood : ~ [2013]
  • Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome
    Flomenberg N Blood 104 : 1923 ~ 1930 - [2004]
  • How I treat: theselection and acquisition of unrelated cord blood grafts
    Barker JN Blood 117 : 2332 ~ 2339 - [2011]
  • Hematopoietic SCTactivity in Asia: a report from the Asia-Pacific Blood andMarrow Transplantation Group
    Yoshimi A Bone Marrow Transplant 45 : 1682 ~ 1691 - [2010]
  • Eurocord-Netcord Registry andEuropean Blood and Marrow Transplant Group. Improvingoutcomes of cord blood transplantation: HLA matching, celldose and other graft- and transplantation-related factors
    Rocha V BrJ Haematol 147 : 262 ~ 274 - [2009]
  • Effect of donor-recipientHLA matching at HLA A, B, C, and DRB1 on outcomesafter umbilical-cord blood transplantation for leukaemia andmyelodysplastic syndrome: a retrospective analysis
    Eapen M LancetOncol 12 : 1214 ~ 1221 - [2011]
  • Effect of HLAmatchingrecipients to donor noninherited maternal antigenson outcomes after mismatched umbilical cord bloodtransplantation for hematologic malignancy
    Rocha V Biol BloodMarrow Transplant 18 : 1890 ~ 1896 - [2012]
  • Donor-specific anti-HLAantibodies predict outcome in double umbilical cord bloodtransplantation
    Cutler C Blood 118 : 6691 ~ 6697 [2011]
  • Current status of pediatricumbilical cord blood transplantation in Korea: a multicenterretrospective analysis of 236 cases
    Yoo KH Am J Hematol 86 : 12 ~ 17 - [2011]
  • Cord blood unit access andselection: 2010 and beyond: best practices and emergingtrends in cord blood unit selection
    Boo M Biol Blood MarrowTransplant 17 (1) : S46 ~ 51 - [2011]
  • Combined effect oftotal nucleated cell dose and HLA match on transplantationoutcome in 1061 cord blood recipients with hematologicmalignancies
    Barker JN Blood 115 : 1843 ~ 1849 - [2010]